Solarcaine

Quick links to important sections

Solarcaine

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Solarcaine

Property Description
Active ingredient Benzocaine (INN)
Form Topical preparations (Spray, Gel, Liquid)
Pharmacological class Local Anesthetic (Amino Ester Class)
Common use Temporary relief of minor pain and itching
Origin Synthetic

What Type of Medicine is Solarcaine? (Identity and Classification)

Solarcaine is an established over-the-counter (OTC) topical pharmaceutical positioned for use as a first aid treatment for minor skin discomfort. Its active ingredient, Benzocaine, is a recognized local anesthetic belonging to the amino ester drug class, a category of compounds known for surface numbing effects. Benzocaine is applied to the skin to cause temporary numbness, relieving pain and discomfort. This positioning confirms the product’s intended role in providing localized surface relief.

The medication is designed exclusively for application to the skin or mucous membranes. This method ensures its effects are non-systemic, meaning its primary action is contained at the treatment site, which differentiates it from oral pain relievers that act internally.

Active Ingredient and Composition (Form and Origin)

The core analgesic effect of Solarcaine is derived from its active ingredient, Benzocaine. This compound is synthetic, chemically known as ethyl 4-aminobenzoate, a substance derived entirely through chemical synthesis. This process ensures its high purity and reliable performance as a topical agent. It is formulated into various pharmaceutical preparations for topical application, commonly available as an aerosol spray, a gel, or a liquid.

What is the General Purpose of Solarcaine? (High-Level Function)

The general purpose of Solarcaine is to achieve rapid, temporary relief from minor pain and associated discomfort, leveraging its analgesic and antipruritic (anti-itch) properties. Its mechanism involves the compound temporarily deadening nerve endings on the skin by blocking the initiation of sensory impulses. Local anesthetics act by stabilizing the neural membrane, thereby preventing pain signal transmission. This function allows the product to reduce the immediate perception of pain and address itching relief resulting from surface irritations.

Regulatory References

  1. NIH: Local Anesthetics
  2. Local Anesthetics - StatPearls - NCBI Bookshelf

What side effects are possible with Solarcaine?

Possible Side Effects and Safety Information

The safety profile for Solarcaine, which contains the local anesthetic benzocaine, is defined by potential risks of systemic absorption and allergic responses, as documented in official regulatory labeling.

Serious Adverse Reactions

The most serious concern noted in regulatory documents is the risk of methemoglobinemia. This is a life-threatening blood disorder where the blood’s ability to carry oxygen is severely reduced. Signs of this reaction include a pale, gray, or blue discoloration of the skin, lips, or nail beds; shortness of breath; headache; and rapid heart rate. Immediate medical attention is required if these symptoms occur.

Other serious, though less common, reactions include anaphylaxis (severe systemic allergic shock) and angioedema (swelling of the deeper layers of skin and tissue).

Common and Local Adverse Reactions

Side effects at the application site are more commonly reported. These include local irritation, burning, stinging, itching (pruritus), and redness (erythema). The development of an allergic skin reaction, known as allergic contact dermatitis, is also a documented possibility, with the risk potentially increasing with repeated or prolonged use.

Population-Specific Safety Considerations

Official regulatory documents contain important restrictions regarding specific populations:

  • Infants and Children Under 2 Years: The product is generally contraindicated (should not be used) in this age group due to their significantly increased risk of developing methemoglobinemia.
  • High-Risk Patients: Caution is advised for use in individuals with pre-existing respiratory issues (such as asthma or emphysema), heart disease, or inherited enzyme deficiencies (like G6PD deficiency), as these conditions increase the risk or severity of methemoglobinemia.

Safety Restrictions and Limitations

Use is not recommended on large areas of the body, deep wounds, puncture wounds, animal bites, or serious burns. The risk of methemoglobinemia is associated with exceeding the recommended amount or frequency of application, and users should not exceed the specified dose or duration.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Solarcaine (Benzocaine) overexposure centers on the risk of developing Acquired Methemoglobinemia, which is classified as a serious and potentially fatal blood disorder. This condition is caused by the systemic absorption of the product, resulting in a significant reduction in the blood's capacity to transport oxygen. Regulatory warnings state this complication can occur following even a single application.

Documented clinical manifestations of this systemic complication include visible signs of impaired oxygen saturation, such as pale, gray, or blue-colored skin (cyanosis), along with symptoms like shortness of breath, headache, rapid heart rate (tachycardia), dizziness, confusion, and fatigue.


When to Seek Immediate Help

The appearance of any of these symptoms mandates a specific emergency response as stated in the official labeling. The patient must stop use of the product immediately and seek immediate medical attention. Furthermore, regulatory guidance instructs users to contact a Poison Control Center right away in an overdose situation. Treatment is classified as symptomatic and supportive, with Methylene blue often utilized as the specific intervention for the complication. Official documents identify high-risk populations, notably infants and children younger than 2 years, the elderly, and individuals with pre-existing heart or breathing problems.

Therapeutic Uses of Solarcaine

What Solarcaine Treats: Main Uses and Benefits

Solarcaine is commonly used in situations involving symptoms related to physical discomfort on the skin's surface, where short-term symptomatic assistance is appropriate. It is commonly used to help with relieving localized pain and itching. The product is considered relevant in contexts involving superficial skin injury and irritation.

The medication is commonly used to help with conditions such as sunburn, minor first-degree burns, minor cuts, scrapes, abrasions, and the discomfort from insect bites or stings. It is also applied when symptoms related to irritative states from exposure to poison ivy or poison oak become more noticeable. It is relevant for managing symptoms that may become intense or disruptive, and contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Surface Pain and Pruritus The medication is commonly used to help with temporary relief of minor pain and itching, which are the primary symptoms associated with common skin irritations and minor injuries.

Eligibility and Restrictions for Use

Who can and cannot use Solarcaine?

Eligibility for Solarcaine (Benzocaine Topical) is determined by official regulatory guidelines, defining specific populations who can use the medicine and those who are contraindicated.

Populations Contraindicated

Use is contraindicated in children under 2 years of age for all over-the-counter benzocaine products due to the risk of a serious blood disorder. Individuals with a known allergy or hypersensitivity to benzocaine or other “caine”-type local anesthetics must also not use the medicine.

Age-Group Eligibility

The product is generally approved for use in adults and children 2 years of age and older. Children under 12 should be supervised. While no specific data on age-related effects are available for geriatric patients, they are identified as a high-risk group for complications.

Condition-Specific Limitations

Caution is necessary for patients with certain comorbidities, including asthma, heart disease, or emphysema, and for smokers. The medicine must not be applied to open wounds, broken skin, serious burns, or over large areas of the body.

Pregnancy and Lactation Status

For pregnancy, the product is classified as Category C, meaning use is only recommended when potential benefit outweighs potential risk. During lactation, application to the breasts or nipples is not recommended to prevent infant ingestion.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Solarcaine (Benzocaine) is primarily defined by documented pharmacodynamic interactions, as regulatory sources do not cite clinically relevant pharmacokinetic interactions (CYP-mediated or transporter effects) for the topical formulation.

Interaction Scope and Constraints

Property Official Regulatory Statement
Interacting Medicinal Categories Sulfonamides; Local Anesthetics; Methemoglobinemia-inducing agents.
Specific Interacting Agents Dapsone; Nitrates and Nitrites (e.g., Nitroglycerin).
Interaction-Related Restrictions Co-administration with Sulfonamide agents must be avoided, as the active ingredient can inhibit the antibacterial action of the sulfonamide (therapeutic antagonism).
Population-Specific Notes The risk of the primary toxic interaction (methemoglobinemia) is officially noted as being higher in Infants, the Elderly, and patients with specific inborn metabolic defects (e.g., G6PD deficiency).

Official Interaction Statements

  • Antagonism: Co-administration with sulfonamides is restricted due to the inhibition of the sulfonamide's therapeutic effect.
  • Additive Toxicity: Concomitant use with other local anesthetics or with methemoglobinemia-inducing agents (such as Dapsone or Nitrates) may result in an additive increase in the risk of methemoglobinemia.

The interaction profile establishes specific co-administration constraints, requiring avoidance of the antagonistic drug class and caution with substances that compound the known toxic effect.

Mechanism of Action

Mechanism: Localized Blockade of Nerve Signaling

The primary action of Benzocaine is the blockade of Voltage-Gated Sodium Channels ( Na^+ VGSCs) found on the surface of peripheral sensory neurons. This mechanism of membrane stabilization prevents the necessary influx of Na^+ ions required for the nerve cell to depolarize and generate an electrical impulse. By suppressing the electrical impulse, the mechanism prevents the conduction of afferent sensory signals toward the central nervous system, resulting in a localized interruption of sensory input.

Onset and Depth: Mechanism-Driven Constraints

Benzocaine's high lipophilicity and low pKa govern its rapid pharmacological profile, enabling fast diffusion across neuronal membranes for quick pathway engagement. However, this same molecular property restricts the drug’s mechanism to superficial nerve endings, constraining its activity to surface-level sensory pathways. The kinetics of the mechanism are further limited by the molecule's rapid absorption into local circulation (vascular washout), leading to a short functional duration of the channel blockade.

Dosage and Administration Information

How to Use Solarcaine: Official Administration Guidelines

The usage of topical Benzocaine, the active ingredient in Solarcaine, is governed by official labeling that defines its specific administration scope and procedural rules. These instructions ensure the medication is used strictly as a localized surface agent and not for systemic purposes. All administration rules are defined by official product labeling.


Administration Scope and Regimen

Entity Official Instruction
Route of Administration The approved route is Topical for localized application to the dermal (skin) or oromucosal (mouth/throat) surfaces. Dermal forms are strictly designated for external use only.
Dosing Schedule Apply a thin layer or one spray directly to the affected area. The labeling restricts use to targeted application and prohibits use on large areas of the body.
Frequency Pattern Application is as needed for temporary discomfort, generally limited to up to 3 or 4 times daily for topical products.
Duration of Use Use is strictly defined as short-term symptomatic relief, and the administration period should not exceed seven consecutive days.

Procedural and Age-Specific Rules

Entity Official Procedural Rule
Preparation Spray forms must be shaken well before use. If treating an insect sting, the stinger must be removed prior to application.
Age Constraints The medication is officially intended for adults and children 2 years of age and older. Children under 12 years of age require supervision during application. Specific oral products carry explicit instructions not to use in children under two years of age.

The official instructions mandate a targeted and intermittent usage protocol. This structured approach, defined by the limited frequency and the strict duration cap, ensures the product's use is contained within the established bounds of temporary surface relief.

Recent Clinical Evidence

Solarcaine: Recent Clinical Evidence

The primary active ingredient in formulations marketed under the Solarcaine name is lidocaine (0.5%), a local anesthetic. In some legacy or international products, benzocaine is used, which functions similarly as a topical anesthetic.

Mechanism of Action

Research on the class of amide-type local anesthetics, such as lidocaine, focuses on their role in nerve signal transmission. The compound functions by temporarily interfering with the movement of sodium ions across nerve cell membranes, which prevents the initiation and conduction of nerve impulses. This action helps to modulate the transmission of pain signals from the site of application.

Clinical Efficacy and Findings

Clinical studies have evaluated the application of topical lidocaine (0.5%) for the temporary relief of pain associated with minor skin conditions. The main focus of research has been on the onset and duration of localized anesthesia related to conditions such as sunburn, minor burns, and general skin irritation. Key findings from clinical evaluations include:

  • Onset of Action: Clinical trials involving patients with superficial burns or sunburn have documented reports of symptomatic relief beginning shortly after application.
  • Pain Score Documentation: Studies have used standardized pain assessment tools (e.g., visual analog scales) to record a reduction in reported pain scores in patients using the topical anesthetic compared to placebo.

These findings characterize the temporary, localized action of the active ingredient for the relief of minor discomfort associated with the indicated skin conditions. Research into the use of topical anesthetics continues to assess optimal concentrations and delivery methods for skin irritation management.

Frequently Asked Questions (FAQ)

Common questions about Solarcaine (FAQ)


Q: Can Solarcaine be used for sunburn relief?

According to the official product labeling, Solarcaine is indicated for the temporary relief of pain and itching associated with sunburn. Its purpose is to help relieve the minor discomfort of common surface irritations like sunburn.


Q: Is Solarcaine available over-the-counter (OTC)?

Yes, Solarcaine is officially categorized as an over-the-counter (OTC) medicine. This means it is available for purchase without a prescription and is intended for use as a first aid treatment for minor skin discomfort.


Q: Do people use Solarcaine for insect bites?

The product's official labeling includes the temporary relief of pain and itching caused by insect bites. This use falls under its general function as a topical anesthetic for minor surface irritations.


Q: Is it common for people to use Solarcaine for minor cuts and scrapes?

Regulatory documents describe the product's use for temporary relief of pain and itching associated with minor cuts and scrapes. However, the label contains restrictions against applying the product to open wounds or serious cuts.


Q: Can children use Solarcaine for skin discomfort?

The product is officially intended for use by adults and children 2 years of age and older. Official guidance states that use is contraindicated (should not be used) in children under 2 years of age.


Q: Is Solarcaine safe for older adults to use?

Official safety information notes that older adults are identified as a high-risk group for the serious adverse reaction of methemoglobinemia. Following all instructions on the application label is necessary.


Q: Are there any known issues with using Solarcaine while taking oral medications?

The product's active ingredient may have pharmacodynamic interactions with certain medicines, such as Sulfonamides and other agents known to induce methemoglobinemia, like Nitrates. These warnings are based on the potential for antagonistic effects or increased risk of side effects.


Q: Can Solarcaine be used on the face?

The official directions describe a specific method for applying the spray formulation to the face. This involves spraying the product into the palm of the hand prior to a gentle application to the affected area.


Q: Can Solarcaine be used near the eyes or mouth?

The labeling explicitly instructs users to keep the product out of the eyes. Additionally, caution is advised to avoid application to or near the mouth and nose, as this may increase the risk of systemic absorption.


Q: Is there an age limit for using Solarcaine, according to official guidance?

Yes, official guidance states the product is contraindicated (should not be used) for all children under 2 years of age. For all other children 2 years and older, the product should be used as directed on the label.


Q: Are there specific parts of the body where Solarcaine should not be applied?

Official restrictions prohibit the use of the product on certain conditions and areas. It must not be applied to open wounds, broken or seriously burned skin, deep wounds, puncture wounds, animal bites, or over large areas of the body.


Q: How does Solarcaine feel when applied to the skin?

Official safety information notes that common local adverse reactions at the application site may include temporary sensations of burning, stinging, irritation, and redness. If these sensations worsen, users should refer to the product label's instructions regarding when to discontinue use.


Q: Are there different forms of Solarcaine (spray, gel, cream)?

The active ingredient in Solarcaine is formulated for topical use and is generally available in various pharmaceutical preparations. These commonly include an aerosol spray, a gel, or a liquid preparation.


Q: How long does the numbing effect of Solarcaine typically last?

The active ingredient is characterized by a rapid onset of action followed by a short functional duration of effect. This short duration is due to the molecule’s characteristics, which lead to its quick absorption into local circulation after application.


Q: What happens if Solarcaine is applied to broken skin?

Applying the product to broken or damaged skin is prohibited because this type of skin may result in increased systemic absorption of the active ingredient. Increased absorption raises the risk of serious side effects, such as methemoglobinemia.


Q: Does Solarcaine expire, and is it still usable after the expiration date?

As an over-the-counter medicine, the product packaging is required to display an expiration date. Regulatory guidance specifies that the medication should not be used past its date of validity to ensure it remains safe and effective as intended.


Q: Has there been research on Solarcaine's primary active ingredient?

Yes, studies have been conducted on the active ingredient's class to document its role in nerve signal transmission. These evaluations have focused on key findings such as the onset of localized pain relief and overall efficacy for minor discomfort.


Q: What is the general expectations regarding Solarcaine's results?

General expectations, as described by its function, are for the product to provide temporary and localized relief from minor pain and discomfort. It is intended for short-term, symptomatic relief of surface irritations.


Q: Can I use Solarcaine if I have a history of skin sensitivity?

Official safety information notes the possibility of local reactions, including irritation and allergic contact dermatitis. The product label advises caution for use in individuals with known sensitivity to local anesthetics, as this may increase the possibility of local reactions.


Q: Does Solarcaine help with swelling?

The official uses described on the label are for temporary relief of pain and itching. Relief of swelling is not listed as an indicated use of the product in regulatory documents.


Q: What is the difference between benzocaine and lidocaine in similar products?

The two compounds belong to different chemical classifications of local anesthetics. Regulatory and chemical documents categorize Benzocaine as an amino ester, while Lidocaine is classified as an amide-type anesthetic.


Q: Is Solarcaine safe for frequent use?

Usage is constrained by the label's directions, limiting application to generally 3 or 4 times daily. Furthermore, official administration guidance specifies that the period of continuous use is restricted to not exceeding seven consecutive days.


Q: Are there any long-term research findings related to Solarcaine's active ingredient?

The product's intended use is strictly defined as short-term relief. Clinical trials and safety warnings have primarily focused on the acute, temporary action and risks associated with its localized application.


Q: Is Solarcaine a prescription or non-prescription drug in my country?

Solarcaine is classified as an over-the-counter (OTC) medicine, meaning it is a non-prescription drug available without requiring a doctor's authorization.


Q: How quickly is Solarcaine absorbed through the skin?

The active ingredient exhibits rapid diffusion across neuronal membranes due to its molecular properties. This rapid absorption allows for a quick onset of action at the application site for temporary relief.

How should Solarcaine be stored and disposed of?

The storage and disposal instructions for Solarcaine, particularly the aerosol spray, are focused on protecting the pressurized container and ensuring child safety, as defined by official regulatory labeling.

Storage Requirements

Official documents mandate that the product must be kept out of reach of children. The pressurized container requires specific temperature control, instructing users to avoid prolonged storage above 40 C (104 F).

Classification Requirement
Temperature Limit Do not exceed 40 C (104 F)
Safety Mandate Keep out of reach of children

Disposal and Handling

Regulatory instructions for the pressurized container require that users do not puncture or incinerate the Solarcaine container at any time. Disposal of the unused or expired product must be carried out in accordance with applicable federal, state, and local regulations for waste materials.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Solarcaine found in:

A-Z Index: